4 line items for gabapentin tablets. Awarded for a base year of 1/1/2019 to 12/31/2019 plus 4 one-year option periods.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79719D0005
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$46,990,217.26
Award type
Single award
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00015 · Change exelan pharmaceuticals, INC. POC from terri arndt to joann bute. $0
Other Administrative Action P00014 · Incorporate updated dscsa language and requirements into VA national contract 36E79719D0005. $0
Add Subcontract Plan P00013 · Incorporate exelan pharmaceuticals, INC. 2023 subcontracting plan for the period of 04/01/2023 - 03/31/2024. $0
Supplemental Agreement for work within scope P00012 · Remove depleted ndcs from contract 36E79719D0005. $0
Exercise an Option P00011 · Exercise the fourth and final option year for gabapentin tablets contract 36E79719D0005 with exelan pharmaceuticals, INC. With no price changes. $0
Add Subcontract Plan P00010 · Incorporate exelan's 2022 subk plan into contract. Plan's effective 4/1/2022 - 3/31/2023. $0
Exercise an Option P00009 · Exercise the third option year for gabapentin tablets, contract 36E79719D0005 with no price changes. Period of performance is 1/1/2022 - 12/31/2022. $0
Supplemental Agreement for work within scope P00008 · Manufacturer/ndcs changes. No price change to any line items. $0
Add Subcontract Plan P00007 · Incorporate exelan's 2021 subk plan into contract. Plan effective 4/1/2021 - 3/30/2022. $0
Exercise an Option P00006 · Exercise the second option year for gabapentin tablets, contract 36E79719D0005 with no price changes. Period of performance is 1/1/2021 - 12/31/2021. $0
Add Subcontract Plan P00005 · Implement exelan's 2020 subk plan, effective from 4/1/2020 to 3/31/2021. $0
Exercise an Option P00004 · Exercise the first option year for gabapentin tablets under contract 36E79719D0005. No price changes. $0
Vendor Address Change P00003 · Implement exelan's address change for gabapentin tablets. $0
Other Administrative Action P00002 · Implement exelan's POC change for gabapentin tablets. $0
Add Subcontract Plan P00001 · Implement exelan's 2019 subcontracting plan for gabapentin tablets dated from 4/1/2019 to 3/31/2020. $0
Original award $0
Show all 16

Quick answers

Who was awarded contract 36E79719D0005?

36E79719D0005 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on January 1, 2019.

How much is contract 36E79719D0005 worth?

36E79719D0005's own ceiling is $46,990,217.

Who can order from contract 36E79719D0005?

36E79719D0005 is a single award indefinite delivery contract.

Was contract 36E79719D0005 competed?

The extent of competition for 36E79719D0005 was full and open competition. The government received 6 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login